Skip to main content
Erschienen in: Obesity Surgery 12/2020

11.09.2020 | Original Contributions

Gut Microbiota Modifications and Weight Regain in Morbidly Obese Women After Roux-en-Y Gastric Bypass

verfasst von: Silvia Leite Faria, Andrey Santos, Daniéla Oliveira Magro, Everton Cazzo, Heloisa Balan Assalin, Dioze Guadagnini, Flavio Teixeira Vieira, Eliane Said Dutra, Mario José Abdalla Saad, Marina K. Ito

Erschienen in: Obesity Surgery | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The relationship between late post-bariatric surgery weight regain and gut microbiota is not completely understood.

Objective

To analyze the profile of gut microbiota among patients with and without late weight regain after post-Roux-en-Y gastric bypass (RYGB) and to compare it with a control group (CG) comprised of obese Brazilian individuals.

Methods

This is a cross-sectional study which enrolled 34 morbidly obese women divided into 3 groups: post-Roux-en-Y gastric bypass without (RYGB_non-regain), and with weight regain (RYGB_regain) at least 5 years after surgery, and a CG of preoperative individuals. Gut microbiota was determined by metagenomic analyses.

Results

The alpha diversity was higher in groups RYGB non-regain and RYGB regain when compared with CG (p < 0.05). Both RYGB non-regain and RYGB regain groups showed a lower abundance of the phylum Bacteroidetes when compared with CG (p < 0.01). The genera Bacteroides and SMB53 were increased in CG (p < 0.05). Group RYGB non-regain showed more abundance of the Akkermansia genus when compared with CG and group RYGB regain (p < 0.05). RYGB non-regain showed a greater abundance of the Phascolarctobacterium genus and lower of the SMB53 genus when compared with CG (p < 0.05). RYGB non-regain showed a greater abundance of the Phascolarctobacterium genus and a lower of the SMB53 genus when compared with CG (p < 0.05).

Conclusion

The gut microbiota of individuals which presented late weight regain after RYGB was significantly different in comparison to individuals with a successful weight loss, a finding that points towards a significant role of gut microbiota on weight loss and maintenance after surgery.
Literatur
1.
Zurück zum Zitat Anhê FF, Varin TV, Schertzer JD, et al. The gut microbiota as a mediator of metabolic benefits after bariatric surgery. Can J Diabetes. 2017;41:439–47.PubMed Anhê FF, Varin TV, Schertzer JD, et al. The gut microbiota as a mediator of metabolic benefits after bariatric surgery. Can J Diabetes. 2017;41:439–47.PubMed
2.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: Primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94. Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: Primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94.
3.
Zurück zum Zitat Magro DO, Geloneze B, Delfini R, et al. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18:648–51.PubMed Magro DO, Geloneze B, Delfini R, et al. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18:648–51.PubMed
4.
Zurück zum Zitat Magro DO, Ueno M, Coelho-Neto JS, et al. Long-term weight loss outcomes after banded Roux-en-Y gastric bypass: a prospective 10-year follow-up study. Surg Obes Relat Dis. 2018;14:910–7.PubMed Magro DO, Ueno M, Coelho-Neto JS, et al. Long-term weight loss outcomes after banded Roux-en-Y gastric bypass: a prospective 10-year follow-up study. Surg Obes Relat Dis. 2018;14:910–7.PubMed
5.
Zurück zum Zitat King WC, Hinerman AS, Belle SH, et al. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA. 2018;320:1560–9.PubMedPubMedCentral King WC, Hinerman AS, Belle SH, et al. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA. 2018;320:1560–9.PubMedPubMedCentral
6.
Zurück zum Zitat Montastier E, Chalret du Rieu M, Tuyeras G, et al. Long-term nutritional follow-up post bariatric surgery. Curr Opin Clin Nutr Metab Care. 2018;21:388–93.PubMed Montastier E, Chalret du Rieu M, Tuyeras G, et al. Long-term nutritional follow-up post bariatric surgery. Curr Opin Clin Nutr Metab Care. 2018;21:388–93.PubMed
7.
Zurück zum Zitat Saad MJA, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology. 2016;31:283–93.PubMed Saad MJA, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology. 2016;31:283–93.PubMed
8.
Zurück zum Zitat Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210–5.PubMed Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210–5.PubMed
9.
Zurück zum Zitat Valentina Tremaroli FK, Werling M, Stahlman M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22:10. Valentina Tremaroli FK, Werling M, Stahlman M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22:10.
10.
Zurück zum Zitat Liou AP, Paziuk M, Luevano JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178ra141. Liou AP, Paziuk M, Luevano JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178ra141.
11.
Zurück zum Zitat Aron-Wisnewsky J, Prifti E, Belda E, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68:70–82.PubMed Aron-Wisnewsky J, Prifti E, Belda E, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68:70–82.PubMed
12.
Zurück zum Zitat Wabitsch M. Gastrointestinal endocrinology in bariatric surgery. Endocr Dev. 2017;32:124–38.PubMed Wabitsch M. Gastrointestinal endocrinology in bariatric surgery. Endocr Dev. 2017;32:124–38.PubMed
13.
Zurück zum Zitat Koutnikova H, Genser B, Monteiro-Sepulveda M, et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019;9:e017995.PubMedPubMedCentral Koutnikova H, Genser B, Monteiro-Sepulveda M, et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019;9:e017995.PubMedPubMedCentral
14.
Zurück zum Zitat Kamvissi-Lorenz V, Raffaelli M, Bornstein S, et al. Role of the gut on glucose homeostasis: lesson learned from metabolic surgery. Curr Atheroscler Rep. 2017;19:9.PubMedPubMedCentral Kamvissi-Lorenz V, Raffaelli M, Bornstein S, et al. Role of the gut on glucose homeostasis: lesson learned from metabolic surgery. Curr Atheroscler Rep. 2017;19:9.PubMedPubMedCentral
15.
Zurück zum Zitat Magouliotis DE, Tasiopoulou VS, Sioka E, et al. Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg. 2017;27:1345–57.PubMed Magouliotis DE, Tasiopoulou VS, Sioka E, et al. Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg. 2017;27:1345–57.PubMed
16.
Zurück zum Zitat Varma S, Clark JM, Schweitzer M, et al. Weight regain in patients with symptoms of post-bariatric surgery hypoglycemia. Surg Obes Relat Dis. 2017;13:1728–34.PubMedPubMedCentral Varma S, Clark JM, Schweitzer M, et al. Weight regain in patients with symptoms of post-bariatric surgery hypoglycemia. Surg Obes Relat Dis. 2017;13:1728–34.PubMedPubMedCentral
17.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
18.
Zurück zum Zitat Illumina 16S metagenomic sequencing library preparation (Illumina Technical Note 15044223) Illumina 16S metagenomic sequencing library preparation (Illumina Technical Note 15044223)
19.
Zurück zum Zitat Lawley B, Tannock GW. Analysis of 16S rRNA gene amplicon sequences using the QIIME software package. Methods Mol Biol. 2017;1537:153–63.PubMed Lawley B, Tannock GW. Analysis of 16S rRNA gene amplicon sequences using the QIIME software package. Methods Mol Biol. 2017;1537:153–63.PubMed
20.
Zurück zum Zitat Kuczynski J, Stombaugh J, Walters WA, González A, Caporaso JG, Knight R. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr Protoc Microbiol 2012: Chapter 1:Unit 1E.5. Kuczynski J, Stombaugh J, Walters WA, González A, Caporaso JG, Knight R. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr Protoc Microbiol 2012: Chapter 1:Unit 1E.5.
21.
Zurück zum Zitat Dhariwal A, Chong J, Habib S, et al. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017;45:W180–8.PubMedPubMedCentral Dhariwal A, Chong J, Habib S, et al. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017;45:W180–8.PubMedPubMedCentral
22.
23.
Zurück zum Zitat Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab. 2015;26:493–501.PubMedPubMedCentral Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab. 2015;26:493–501.PubMedPubMedCentral
24.
Zurück zum Zitat Zhu J, Gupta R, Safwa M. The mechanism of metabolic surgery: gastric center hypothesis. Obes Surg. 2016;26:1639–41.PubMed Zhu J, Gupta R, Safwa M. The mechanism of metabolic surgery: gastric center hypothesis. Obes Surg. 2016;26:1639–41.PubMed
25.
Zurück zum Zitat Tseng CH, Wu CY. The gut microbiome in obesity. J Formos Med Assoc. 2019;118(Suppl 1):S3–9.PubMed Tseng CH, Wu CY. The gut microbiome in obesity. J Formos Med Assoc. 2019;118(Suppl 1):S3–9.PubMed
26.
Zurück zum Zitat Muscogiuri G, Cantone E, Cassarano S, et al. On behalf of the obesity programs of nutrition E, R.search and assessment (OPERA) group: gut microbiota: a new path to treat obesity. Int J Obes Suppl. 2019;9:10–9.PubMedPubMedCentral Muscogiuri G, Cantone E, Cassarano S, et al. On behalf of the obesity programs of nutrition E, R.search and assessment (OPERA) group: gut microbiota: a new path to treat obesity. Int J Obes Suppl. 2019;9:10–9.PubMedPubMedCentral
27.
Zurück zum Zitat Shen N, Caixàs A, Ahlers M, et al. Longitudinal changes of microbiome composition and microbial metabolomics after surgical weight loss in individuals with obesity. Surg Obes Relat Dis. 2019;15:1367–73.PubMedPubMedCentral Shen N, Caixàs A, Ahlers M, et al. Longitudinal changes of microbiome composition and microbial metabolomics after surgical weight loss in individuals with obesity. Surg Obes Relat Dis. 2019;15:1367–73.PubMedPubMedCentral
28.
Zurück zum Zitat Levin AM, Sitarik AR, Havstad SL, et al. Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity. Sci Rep. 2016;6:31775.PubMedPubMedCentral Levin AM, Sitarik AR, Havstad SL, et al. Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity. Sci Rep. 2016;6:31775.PubMedPubMedCentral
29.
Zurück zum Zitat Hughes RL. A review of the role of the gut microbiome in personalized sports nutrition. Front Nutr. 2019;6:191.PubMed Hughes RL. A review of the role of the gut microbiome in personalized sports nutrition. Front Nutr. 2019;6:191.PubMed
30.
Zurück zum Zitat Nakayama J, Yamamoto A, Palermo-Conde LA, et al. Impact of westernized diet on gut microbiota in children on Leyte Island. Front Microbiol. 2017;8:197.PubMedPubMedCentral Nakayama J, Yamamoto A, Palermo-Conde LA, et al. Impact of westernized diet on gut microbiota in children on Leyte Island. Front Microbiol. 2017;8:197.PubMedPubMedCentral
31.
Zurück zum Zitat Ou J, Carbonero F, Zoetendal EG, et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 2013;98:111–20.PubMedPubMedCentral Ou J, Carbonero F, Zoetendal EG, et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 2013;98:111–20.PubMedPubMedCentral
32.
Zurück zum Zitat Murugesan S, Ulloa-Martínez M, Martínez-Rojano H, et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J Clin Microbiol Infect Dis. 2015;34:1337–46.PubMed Murugesan S, Ulloa-Martínez M, Martínez-Rojano H, et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J Clin Microbiol Infect Dis. 2015;34:1337–46.PubMed
33.
Zurück zum Zitat Guo Y, Huang ZP, Liu CQ, et al. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Eur J Endocrinol. 2018;178:43–56.PubMed Guo Y, Huang ZP, Liu CQ, et al. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Eur J Endocrinol. 2018;178:43–56.PubMed
34.
Zurück zum Zitat Ulker İ, Yildiran H. The effects of bariatric surgery on gut microbiota in patients with obesity: a review of the literature. Biosci Microbiota Food Health. 2019;38:3–9.PubMed Ulker İ, Yildiran H. The effects of bariatric surgery on gut microbiota in patients with obesity: a review of the literature. Biosci Microbiota Food Health. 2019;38:3–9.PubMed
35.
Zurück zum Zitat Avram-Hananel L, Stock J, Parlesak A, et al. E durans strain M4-5 isolated from human colonic flora attenuates intestinal inflammation. Dis Colon Rectum. 2010;53:1676–86.PubMed Avram-Hananel L, Stock J, Parlesak A, et al. E durans strain M4-5 isolated from human colonic flora attenuates intestinal inflammation. Dis Colon Rectum. 2010;53:1676–86.PubMed
36.
Zurück zum Zitat Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8:67.PubMedPubMedCentral Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8:67.PubMedPubMedCentral
37.
Zurück zum Zitat Kurihara S, Kato K, Asada K, et al. A putrescine-inducible pathway comprising PuuE-YneI in which gamma-aminobutyrate is degraded into succinate in Escherichia coli K-12. J Bacteriol. 2010;192:4582–91.PubMedPubMedCentral Kurihara S, Kato K, Asada K, et al. A putrescine-inducible pathway comprising PuuE-YneI in which gamma-aminobutyrate is degraded into succinate in Escherichia coli K-12. J Bacteriol. 2010;192:4582–91.PubMedPubMedCentral
38.
Zurück zum Zitat Urbain JL, Penninckx F, Siegel JA, et al. Effect of proximal vagotomy and Roux-en-Y diversion on gastric emptying kinetics in asymptomatic patients. Clin Nucl Med. 1990;15:688–91.PubMed Urbain JL, Penninckx F, Siegel JA, et al. Effect of proximal vagotomy and Roux-en-Y diversion on gastric emptying kinetics in asymptomatic patients. Clin Nucl Med. 1990;15:688–91.PubMed
39.
Zurück zum Zitat Cornejo-Pareja I, Martín-Núñez GM, Roca-Rodríguez MM, Cardona F, Coin-Aragüez L, Sánchez-Alcoholado L, Gutiérrez-Repiso C, Muñoz-Garach A, Fernández-García JC, Moreno-Indias I, Tinahones FJ. Eradication treatment alters gut microbiota and GLP-1 secretion in humans. J Clin Med 2019: 8. Cornejo-Pareja I, Martín-Núñez GM, Roca-Rodríguez MM, Cardona F, Coin-Aragüez L, Sánchez-Alcoholado L, Gutiérrez-Repiso C, Muñoz-Garach A, Fernández-García JC, Moreno-Indias I, Tinahones FJ. Eradication treatment alters gut microbiota and GLP-1 secretion in humans. J Clin Med 2019: 8.
40.
Zurück zum Zitat Zupancic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS One. 2012;7:e43052.PubMedPubMedCentral Zupancic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS One. 2012;7:e43052.PubMedPubMedCentral
41.
Zurück zum Zitat Chevalier C, Stojanović O, Colin DJ, et al. Gut microbiota orchestrates energy homeostasis during cold. Cell. 2015;163:1360–74.PubMed Chevalier C, Stojanović O, Colin DJ, et al. Gut microbiota orchestrates energy homeostasis during cold. Cell. 2015;163:1360–74.PubMed
42.
Zurück zum Zitat Debédat J, Clément K, Aron-Wisnewsky J. Gut microbiota Dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8:229–42.PubMed Debédat J, Clément K, Aron-Wisnewsky J. Gut microbiota Dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8:229–42.PubMed
43.
Zurück zum Zitat Muñiz Pedrogo DA, Jensen MD, Van Dyke CT, et al. Gut microbial carbohydrate metabolism hinders weight loss in overweight adults undergoing lifestyle intervention with a volumetric diet. Mayo Clin Proc. 2018;93:1104–10.PubMed Muñiz Pedrogo DA, Jensen MD, Van Dyke CT, et al. Gut microbial carbohydrate metabolism hinders weight loss in overweight adults undergoing lifestyle intervention with a volumetric diet. Mayo Clin Proc. 2018;93:1104–10.PubMed
44.
Zurück zum Zitat Serena C, Ceperuelo-Mallafré V, Keiran N, et al. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 2018;12:1642–57.PubMedPubMedCentral Serena C, Ceperuelo-Mallafré V, Keiran N, et al. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 2018;12:1642–57.PubMedPubMedCentral
45.
Zurück zum Zitat Nirmalkar K, Murugesan S, Pizano-Zárate ML, et al. Gut microbiota and endothelial dysfunction markers in obese Mexican children and adolescents. Nutrients. 2018;10 Nirmalkar K, Murugesan S, Pizano-Zárate ML, et al. Gut microbiota and endothelial dysfunction markers in obese Mexican children and adolescents. Nutrients. 2018;10
46.
Zurück zum Zitat Ziętak M, Kovatcheva-Datchary P, Markiewicz LH, et al. Altered microbiota contributes to reduced diet-induced obesity upon cold exposure. Cell Metab. 2016;23:1216–23.PubMedPubMedCentral Ziętak M, Kovatcheva-Datchary P, Markiewicz LH, et al. Altered microbiota contributes to reduced diet-induced obesity upon cold exposure. Cell Metab. 2016;23:1216–23.PubMedPubMedCentral
47.
Zurück zum Zitat Liu TW, Cephas KD, Holscher HD, et al. Nondigestible Fructans alter gastrointestinal barrier function, gene expression, histomorphology, and the microbiota profiles of diet-induced obese C57BL/6J mice. J Nutr. 2016;146:949–56.PubMed Liu TW, Cephas KD, Holscher HD, et al. Nondigestible Fructans alter gastrointestinal barrier function, gene expression, histomorphology, and the microbiota profiles of diet-induced obese C57BL/6J mice. J Nutr. 2016;146:949–56.PubMed
48.
Zurück zum Zitat Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152:398–414.e396.PubMed Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152:398–414.e396.PubMed
Metadaten
Titel
Gut Microbiota Modifications and Weight Regain in Morbidly Obese Women After Roux-en-Y Gastric Bypass
verfasst von
Silvia Leite Faria
Andrey Santos
Daniéla Oliveira Magro
Everton Cazzo
Heloisa Balan Assalin
Dioze Guadagnini
Flavio Teixeira Vieira
Eliane Said Dutra
Mario José Abdalla Saad
Marina K. Ito
Publikationsdatum
11.09.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 12/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04956-9

Weitere Artikel der Ausgabe 12/2020

Obesity Surgery 12/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.